For the Inventor, By the Inventor

Enter assignee name

Prometic Biosciences Inc.

USPTO Granted Patents = 30

CIPO Patents = 13

EPO Patents = 15

Trademarks = 3

Forward Citations = 99

Loading Chart...

Loading Chart...

45 inventors (with patents filed for the assignee):

Christopher L Penney (13 out of 21 patents)

Lyne Gagnon (11 out of 28 patents)

Boulos Zacharie (11 out of 29 patents)

4. Brigitte Grouix (7 out of 19 patents)

5. Jason Richard Betley (6 out of 16 patents)

6. James Christopher Pearson (6 out of 12 patents)

7. Pierre Laurin (5 out of 16 patents)

8. Christopher Robin Lowe (5 out of 32 patents)

9. Lilianne Geerts (4 out of 7 patents)

10. Shaun Abbott (3 out of 9 patents)

11. Jean-François Bienvenu (3 out of 4 patents)

12. Steven James Burton (3 out of 14 patents)

13. Ben Martin Beacom (3 out of 3 patents)

14. Tadeusz Antoni Podgorski (3 out of 3 patents)

15. Helen Rosemary Tatton (3 out of 3 patents)

30 patents: Sort by Forward Citations

1. 9475750 - Phenylketone carboxylate compounds and pharmaceutical uses thereof (2016-10-25),

2. 9439882 - Compounds and compositions for the treatment of cancer (2016-09-13),

3. 9221768 - Affinity adsorbents for fibrinogen (2015-12-29),

4. 9114118 - Compounds and compositions for the treatment of cancer (2015-08-25),

5. 8946190 - Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer (2015-02-03),

6. 8927765 - Substituted aromatic compounds and pharmaceutical uses thereof (2015-01-06),

7. 8765393 - Endotoxin-binding ligands and their use (2014-07-01),

8. 8637574 - Salts of 3-pentylphenylacetic acid and pharmaceutical uses thereof (2014-01-28),

9. 8551994 - Affinity adsorbents for fibrinogen (2013-10-08),

10. 8501939 - Triazines and pyrimidines as protein binding ligands (2013-08-06),

11. 8487001 - Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors (2013-07-16),

12. 8258295 - Triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives (2012-09-04),

13. 8198407 - Sequential protein isolation and purification schemes by affinity chromatography (2012-06-12),

14. 8080555 - Purine derivatives and their use for treatment of autoimmune diseases (2011-12-20),

15. 8076477 - Adsorbents for protein purification (2011-12-13),

ProMetic BioSciences Inc. is a biopharmaceutical company focusing on developing small molecule therapies for the treatment of various diseases. They utilize their proprietary drug discovery platform to identify and develop novel therapeutics. Their areas of expertise include fibrosis, lymphedema, sepsis, and ophthalmology. ProMetic aims to improve patients' quality of life and provide innovative solutions to unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

30 Patents

#2 in Laval

#436 in Canada

#21,229 in the World

Prometic Biosciences Inc.

Forward Citations = 99

45 inventors:

Christopher L Penney (13 out of 21 patents)

Lyne Gagnon (11 out of 28 patents)

Boulos Zacharie (11 out of 29 patents)

4. Brigitte Grouix (7 out of 19 patents)

5. Jason Richard Betley (6 out of 16 patents)

Please report any incorrect information to support@idiyas.com

Loading…